Aurinia Pharmaceuticals : to Present at Cowen and Company 35th Annual Health Care Conference

For Immediate Release

35th Annual Health Care Conference on Monday March 2nd at 2:50 pm Eastern Time. The conference will take place at the Boston Marriot Copley Place Hotel in Boston, MA.

A live audio webcast and archive of the event will be available at:

http://wsw.com/webcast/cowen22/auph

To ensure a timely connection to the webcast, it is recommended that users register at least 15 minutes prior to the scheduled start time.

The corporate overview being presented and the archived version of the webcast will also be available on the Company website at www.auriniapharma.com following the presentation.

Aurinia is a clinical stage pharmaceutical company focused on the global nephrology market. It is currently enrolling patients in its Phase 2b clinical trial to evaluate the efficacy of its drug, voclosporin, as a treatment for lupus nephritis ("LN"). LN is an inflammation of the kidneys, that
if inadequately treated can lead to end-stage renal disease, making LN a serious and potentially life-threatening condition.
Voclosporin is a novel and potentially best in class calcineurin inhibitor ("CNI") with extensive clinical data in over 2,600 patients in other indications. Voclosporin is made by a modification of a single amino acid of the cyclosporine molecule (a CNI approved for use in transplant patients since 1983). This modification results in a more predictable pharmacokinetic and pharmacodynamic relationship, an increase in potency vs. cyclosporine, an altered metabolic profile, and potential for flat dosing.

Aurinia also has development and commercialization partners in Canada, Israel, South Africa and Greater China. Visit www.auriniapharma.com, www.sedar.com and www.sec.gov for more information.

Visit www.auriniapharma.comfor more information.

Michael R. Martin

Chief Operating Officer

250-708-4272 mmartin@auriniapharma.com

Stephen Zaruby

President & Chief Executive Officer

250-708-4293 szaruby@auriniapharma.com

distributed by